Nature of Business and Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Schedule of revenues disaggregated by revenue source
The following table presents the Company’s revenues disaggregated by revenue source (in thousands):
 
    
Year Ended December 31,
  
    
2021
     
2020
     
2019
  
Enterprise
    $ 243,404      $ 188,339      $ 202,641  
Provider
      90,921        79,324        80,726  
Life Sciences
      78,490        61,142        56,174  
  
 
 
     
 
 
     
 
 
  
Total Revenue
    $ 412,815      $ 328,805      $ 339,541  
  
 
 
     
 
 
     
 
 
  
Schedule of other expenses (income)
For the years ended December 31, 2021, 2020, and 2019, other income (expense) consisted of the following (in thousands):
 
    
Year Ended December 31,
  
    
2021
     
2020
     
2019
  
Re-measurement
of contingent consideration
    $ 13,447      $ (6,211 )     $ (472 ) 
Re-measurement
of warrant liabilities
      12,676        (3,436 )       (94 ) 
Other
      884        (62 )       (242 ) 
  
 
 
     
 
 
     
 
 
  
Total other income (expense)
    $ 27,007      $ (9,709 )     $ (808 )